Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 rna

Journal of Infectious Diseases

Volumn 170, Issue 3, 1994, Pages 553-562

  Lin, Hsiang Ju ^{a,b,c,d,e,f,g,h,i}   Myers, Lawrence E ^{a,b,c,d,e,f,g,h,i}   Yen Lieberman, Belinda ^{a,b,c,d,e,f,g,h,i}   Blaine Hollinger, F ^{a,b,c,d,e,f,g,h,i}   Henrard, Denis ^{a,b,c,d,e,f,g,h,i}   Hooper, Carol J ^{a,b,c,d,e,f,g,h,i}   Kokka, Robert ^{a,b,c,d,e,f,g,h,i}   Kwok, Shirley ^{a,b,c,d,e,f,g,h,i}   Rasheed, Suraiya ^{a,b,c,d,e,f,g,h,i}   Vahey, Maryanne ^{a,b,c,d,e,f,g,h,i}   Winters, Mark A ^{a,b,c,d,e,f,g,h,i}   Mc Quay, Lisa J ^{a,b,c,d,e,f,g,h,i}   Nara, Peter L ^{a,b,c,d,e,f,g,h,i}   Reichelderfer, Patricia ^{a,b,c,d,e,f,g,h,i}   Coombs, Robert W ^{a,b,c,d,e,f,g,h,i}   Brooks Jackson, J ^{a,b,c,d,e,f,g,h,i}  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d ABBOTT LABORATORIES   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; VIRUS RNA;

ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTICENTER STUDY; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE DIAGNOSIS; SEROLOGY; VIREMIA; VIRUS DETECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD SPECIMEN COLLECTION; CD4-POSITIVE T-LYMPHOCYTES; COMPARATIVE STUDY; HIV CORE PROTEIN P24; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMAN; LABORATORIES; LEUKOCYTE COUNT; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIREMIA;

EID: 0028092998     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.3.553     Document Type: Article

References (29)

1. Cohen J. Searching for markers on the AIDS trail. Science 1992;258:388-90.
2. Hammer S, Crumpacker C, D’Aquila R, etal. Use ofvirologic assays for the detection of human immunodeficiency virus in clinical trials: Recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol 1993;31:2557-64.
3. Aboulker JP, Swart AM. Preliminary analysis of the Concorde trial. Lancet 1993;341:889-90.
4. Saag MS, Emini E, Laskin OL, et al. A short-term clinical evaluation of L-697, 661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. N Engl J Med 1993;329:1065-72.
5. Nishanian P, Huskins KR, Stehn S, Detels R, Fahey JL. A simple method for improved assay that demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis 1990; 162:21-8.
6. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989; 321:162-631.
7. Coombs RW, Henrard DR, Mehatfey WF, et al. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol 1993;31:1980-6.
8. Urdea MS. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, and HIV. Clin C'hem 1993;39:725-6.
9. Holodniy M, Katzenstein DA, Sengupta S, et al. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis 1991; 163:862-6.
10. Piatak M, Saag MS, Yang LC, et al. High levels of HIV-I in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
11. Semple M, Loveday C, Weller I, Tedder R. Direct measurement of viremia in patients infected with HI V-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991;35:38-45.
12. Holodniy M, Katzenstein DA, Israelski DM, Merigan TC. Reduction in plasma human immunodeficiency virus ribonucleic acid after di-deoxynucleoside therapy as determined by the polymerase chain reaction. J Clin Invest 1991;88:1755-9.
13. Holodniy M, Katzenstein D, Winters M, et al. Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy. J Acquir Immune DeficSyndr 1993;6:366-9.
14. Aoki-Sei S., Yarchoan R, Kageyama S, et al. Plasma HIV-l-infected individuals assessed by polymerase chain reaction. AIDS Res Hum Retroviruses 1992;8:1263-70.
15. Collier AC, Coombs RW, Fischl MA, et al. Combination therapy with zidovudine and didanosine compared to zidovudine alone in human immunodeficiency virus type one infection. Ann Intern Med 1993;119:786-93.
16. Winters MA, Tan LB, Katzenstein DA, Merigan TC. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1993;31:2960-6.
17. Lori F, di Marzo Veronese F, De Vico AL, Lusso P, Reitz MS Jr. Gallo RC. Viral DNA carried by human immunodeficiency type I virions. J Virol 1992;66:5067-74.
18. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992;66:4893-900.
19. Layne SP, Merges MJ, Dembo M, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992; 189:695-714.
20. Hollinger FB, Bremer JW, Myers LE, Gold JWM, Mc Quay L, the N1H/NIAID/DAIDS/ACTG Virology Laboratories. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-94.
21. Hollinger FB. ed. ACTG manual for HIV laboratories. Version 2.0. Bethesda, MD: Division of AIDS, National Institute of Allergy and Infectious Diseases, 1993.
22. Kageyama S, Yamada O, Mohammad S, et al. An improved method for the detection of HIV antigen in blood of carriers. J Virol Methods 1988;22:125-31.
23. Whetsell AJ., Drew JB, Milman G, et al. Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1. J Clin Microbiol 1992;30:845-53.
24. Mulder J. Mc Kinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. A rapid and simple PCR assay for quantitation of HIV-1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
25. Henrard D, Mehaffey WF, Allain JP. A sensitive viral capture assay for detection of plasma viremia in HIV-infected individuals. AIDS Res Hum Retroviruses 1992;8:47-52.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Bio-chem 1987;162:156-9.
27. Folks TM, Powell D, Lightfoote M, et al. Biological and biochemical characterization of a cloned leu-3_ cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986;164:280-90.
28. Schochetman G, Sninsky JJ. Direct detection of human immunodeficiency virus infection using the polymerase chain reaction. In: Schochetman G, George JR, eds. AIDS testing methodology and management issues. New York: Springer-Verlag, 1992:90-110.
29. Johnson RF, Pickett SC, Barker DL. Autoradiography using phosphor technology. Electrophoresis 1990; 11:355-60.